Bedel Financial Consulting, Inc. Astrazeneca PLC Transaction History

Bedel Financial Consulting, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	BUY	$55.72 - $67.12 $1,615 - $1,946	29 Added 0.67%	4,329 $287,000
Q3 2021 Oct 12, 2021	BUY	$55.56 - $60.79 $833 - $911	15 Added 0.35%	4,300 $258,000
Q1 2021 Apr 26, 2021	BUY	$47.16 - $54.44 $110,118 - $127,117	2,335 Added 119.74%	4,285 $213,000
Q3 2020 Oct 20, 2020	BUY	$53.07 - $61.1 $103,486 - $119,145	1,950 New	1,950 $107,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.